| Andrew Richard Crichlow, MD | |
|
18229 Dupont Blvd, Georgetown, DE 19947-3127 | |
| (302) 514-7246 | |
| (302) 253-8028 |
| Full Name | Andrew Richard Crichlow |
|---|---|
| Gender | Male |
| Speciality | Interventional Pain Management |
| Experience | 12 Years |
| Location | 18229 Dupont Blvd, Georgetown, Delaware |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1861753386 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207LP2900X | Anesthesiology - Pain Medicine | 0101262218 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Beebe Medical Center | Lewes, DE | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Delaware Anesthesia Associates Pa | 6305825894 | 36 |
News Archive
Bristol-Myers Squibb Company and ZymoGenetics, Inc. (NASDAQ:ZGEN) announced that final results from a Phase 1b clinical trial in patients with hepatitis C (HCV) treated with PEG-Interferon lambda, a new class of interferon, in combination with ribavirin will be presented at the American Association for the Study of Liver Diseases (AASLD) annual meeting October 30–November 3, 2009, in Boston.
Though the economy seems to be trumping the health law on the campaign trail, the overhaul is one of the flashpoints in what the New York Times describes as a "philosophic clash" over the role of the federal government. Meanwhile, President Barack Obama, campaigning in Florida, is expected to talk Medicare. In the background, Vice President Joseph Biden says Obama expected the political backlash triggered by the health law.
Sanford Heart Hospital has started a clinical trial to study a dissolving device in patients with coronary artery disease. The ABSORB III clinical trial will investigate the safety and effectiveness of the Absorb Bioresorbable Vascular Scaffold (BVS) device, manufactured by global health care company Abbott.
For much of the 20th century, summer was considered "polio season," and people were accustomed to seeing swimming pools and movie theaters closed to stave off the latest epidemic. Shaking hands was off limits, and even touching money was perilous.
› Verified 1 days ago
| Entity Name | Delaware Anesthesia Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578618930 PECOS PAC ID: 6305825894 Enrollment ID: O20040719000033 |
News Archive
Bristol-Myers Squibb Company and ZymoGenetics, Inc. (NASDAQ:ZGEN) announced that final results from a Phase 1b clinical trial in patients with hepatitis C (HCV) treated with PEG-Interferon lambda, a new class of interferon, in combination with ribavirin will be presented at the American Association for the Study of Liver Diseases (AASLD) annual meeting October 30–November 3, 2009, in Boston.
Though the economy seems to be trumping the health law on the campaign trail, the overhaul is one of the flashpoints in what the New York Times describes as a "philosophic clash" over the role of the federal government. Meanwhile, President Barack Obama, campaigning in Florida, is expected to talk Medicare. In the background, Vice President Joseph Biden says Obama expected the political backlash triggered by the health law.
Sanford Heart Hospital has started a clinical trial to study a dissolving device in patients with coronary artery disease. The ABSORB III clinical trial will investigate the safety and effectiveness of the Absorb Bioresorbable Vascular Scaffold (BVS) device, manufactured by global health care company Abbott.
For much of the 20th century, summer was considered "polio season," and people were accustomed to seeing swimming pools and movie theaters closed to stave off the latest epidemic. Shaking hands was off limits, and even touching money was perilous.
› Verified 1 days ago
| Entity Name | Sussex Pain Relief Center, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578886180 PECOS PAC ID: 8325171887 Enrollment ID: O20100804000421 |
News Archive
Bristol-Myers Squibb Company and ZymoGenetics, Inc. (NASDAQ:ZGEN) announced that final results from a Phase 1b clinical trial in patients with hepatitis C (HCV) treated with PEG-Interferon lambda, a new class of interferon, in combination with ribavirin will be presented at the American Association for the Study of Liver Diseases (AASLD) annual meeting October 30–November 3, 2009, in Boston.
Though the economy seems to be trumping the health law on the campaign trail, the overhaul is one of the flashpoints in what the New York Times describes as a "philosophic clash" over the role of the federal government. Meanwhile, President Barack Obama, campaigning in Florida, is expected to talk Medicare. In the background, Vice President Joseph Biden says Obama expected the political backlash triggered by the health law.
Sanford Heart Hospital has started a clinical trial to study a dissolving device in patients with coronary artery disease. The ABSORB III clinical trial will investigate the safety and effectiveness of the Absorb Bioresorbable Vascular Scaffold (BVS) device, manufactured by global health care company Abbott.
For much of the 20th century, summer was considered "polio season," and people were accustomed to seeing swimming pools and movie theaters closed to stave off the latest epidemic. Shaking hands was off limits, and even touching money was perilous.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Andrew Richard Crichlow, MD 18229 Dupont Blvd, Georgetown, DE 19947-3127 Ph: (302) 514-7246 | Andrew Richard Crichlow, MD 18229 Dupont Blvd, Georgetown, DE 19947-3127 Ph: (302) 514-7246 |
News Archive
Bristol-Myers Squibb Company and ZymoGenetics, Inc. (NASDAQ:ZGEN) announced that final results from a Phase 1b clinical trial in patients with hepatitis C (HCV) treated with PEG-Interferon lambda, a new class of interferon, in combination with ribavirin will be presented at the American Association for the Study of Liver Diseases (AASLD) annual meeting October 30–November 3, 2009, in Boston.
Though the economy seems to be trumping the health law on the campaign trail, the overhaul is one of the flashpoints in what the New York Times describes as a "philosophic clash" over the role of the federal government. Meanwhile, President Barack Obama, campaigning in Florida, is expected to talk Medicare. In the background, Vice President Joseph Biden says Obama expected the political backlash triggered by the health law.
Sanford Heart Hospital has started a clinical trial to study a dissolving device in patients with coronary artery disease. The ABSORB III clinical trial will investigate the safety and effectiveness of the Absorb Bioresorbable Vascular Scaffold (BVS) device, manufactured by global health care company Abbott.
For much of the 20th century, summer was considered "polio season," and people were accustomed to seeing swimming pools and movie theaters closed to stave off the latest epidemic. Shaking hands was off limits, and even touching money was perilous.
› Verified 1 days ago
Dr. Manonmani Antony, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 18229 Dupont Blvd, Georgetown, DE 19947 Phone: 302-519-0100 Fax: 302-253-8028 |